UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 21, 2019
Accession Number:
Submission Type:
CIK:
0000715446
Company Name:
Anixa Biosciences Inc
File Number:
333-232067